← Research library / Hormonal

Kisspeptin-10: What the Evidence Actually Shows

Grade B research settingNo US approval

The short version

  • A neuropeptide that sits upstream of GnRH in the reproductive axis.
  • Its discovery genuinely changed reproductive endocrinology. This is real science.
  • Used in research settings to probe the axis and in fertility research.
  • Not approved for the libido and testosterone uses it is sold for.
  • Very short half life, measured in minutes.

What it is

Kisspeptin is encoded by the KISS1 gene and acts on the KISS1R receptor in the hypothalamus. It is the signal that triggers GnRH release, which in turn drives LH and FSH, which drive gonadal hormone production. Loss of function mutations cause failure of puberty, which is how its role was discovered.

That makes it genuinely upstream, further back in the chain than anything else commonly sold in this space.

What the research shows

There is legitimate academic work using kisspeptin to investigate hypothalamic function, in fertility research including as a trigger in IVF protocols, and in studies of sexual arousal pathways. Some of that work has produced interesting findings about central arousal circuits.

What does not exist is a trial base supporting the way it is marketed to consumers: repeated self-administration for libido or testosterone. The very short half life also means the dosing patterns circulating online have no clear relationship to how it was studied.

What this will not do

Related

Full library · Safety and sourcing · Reconstitution calculator · The 2026 regulatory picture

Regulatory status current as of the page date. This area is changing quickly and this page is reviewed monthly.